However, age alone cannot reliably identify those at risk for an HHMS—two patients who received a genetic diagnosis of HHMS in our cohort (DDX41 and RUNX1) were over age fifty at the time of their AML/MDS diagnosis. This evidence concerns the gene RUNX1 and acute myeloid leukemia.